[Article 1.33] is hereby deleted in its entirety and replaced as follows:

[Article 1.50] is hereby deleted in its entirety and replaced as follows:

[Article 1.75] is hereby deleted in its entirety and replaced as follows:

[Article 4.3(e)] is hereby deleted in its entirety and replaced as follows:

[Article 12.7] is hereby deleted in its entirety and replaced as follows:

[Article 13.2(b)] is deleted in its entirety and replaced with the following:

[Article 13.2(f)] is deleted in its entirety and replaced with the following:

[Article 13.3] is deleted in its entirety and replaced with the following:

[Article 14.1(c)] shall not apply to the China Territory, for which the provisions below that are more specific shall apply

[Article 2.5] shall not apply in the event that, Synthon, Sanquin, their Affiliates or (sub)licensees make, assert, initiate, bring, engage in, file, finance, aid, assist or participate in any action or proceeding against Forty Seven, its Affiliates or its (sub)licensees alleging infringement of any Licensed Patent Rights, including the sending of cease and desist letters or taking other actions that would satisty the criteria for initiation of a declaratory judgment action in U.S. district court, in which case Forty Seven, its Affiliates or its (sub)licensees shall have the right to assert any action, defence and/or counterclaim, including asserting the invalidity of the Licensed Patent Rights, that would have been available to them in the absence of this Agreement. If such action is taken by Synthon, Sanquin, and their Affiliates or (sub)licensees in the United Kingdom, Synthon shall not, and Synthon shall procure that SSB, its Affiliates and SSB’s Affiliates and their (sub)licensees shall not, object to any subsequent counterclaim for revocation of the UK Patent by Forty Seven, its Affiliates or (sub)licensees. For the avoidance of doubt, Synthon, Sanquin, their Affiliates or (sub)licensees may defend any such counterclaim for revocation.